Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $75.27 | $17.33 | 334.23% | 313.63x | 21.91x | 23.00x | 61.65x | 1.54x | $41.15M | 0.62% | $108.58M | 1.23 | $6.65B | 124.18 | ||
| CORT | CORCEPT THERAPEUTICS INC | $89.72 | $23.70 | 278.56% | 195.04x | 150.36x | 12.18x | 15.10x | 1.39x | $119.79M | 1.28% | $637.99M | 6.11 | $9.53B | -1,388.36 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.69 | $2.77 | 213.60% | 124.14x | 76.29x | 4.71x | 115.31x | 1.19x | $47.52M | 3.21% | $13.01M | 0.08 | $1.65B | 30.83 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $283.15 | $91.49 | 209.50% | 64.94x | 37.81x | 8.78x | 35.15x | 1.35x | $641.34M | 1.70% | $1.08B | 8.09 | $39.06B | 42.25 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.54 | $69.94 | 10.87% | 26.20x | 9.34x | 6.07x | 41.87x | 0.47x | $667.65M | 7.29% | $219.64M | 1.86 | $11.03B | 17.68 | ||
| KRYS | KRYSTAL BIOTECH INC | $341.79 | $93.52 | 265.48% | 44.10x | 43.66x | 23.99x | 7.89x | 2.11x | $237.38M | 2.37% | $1.28B | 43.59 | $9.58B | 44.79 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $61.11 | $16.98 | 259.82% | 62.36x | 47.87x | 6.20x | 7.76x | 1.69x | $164.23M | 3.51% | $605.69M | 7.92 | $4.52B | 40.55 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.00 | $39.57 | 51.64% | 42.86x | 16.24x | 3.56x | 1.87x | 0.61x | $767.06M | 6.64% | $6.21B | 32.27 | $9.95B | 20.63 | ||
| VCEL | VERICEL CORP | $47.81 | $8.96 | 433.69% | 111.19x | 99.17x | 8.31x | 6.85x | 2.34x | $47.49M | 1.96% | $356.23M | 7.02 | $2.43B | 60.04 | ||
| RPRX | ROYALTY PHARMA PLC | $58.53 | $39.11 | 49.67% | 30.64x | 10.97x | 10.48x | 3.39x | 0.66x | $2.34B | 9.16% | $9.94B | 22.75 | $42.07B | 36.16 | ||
| ADMA | ADMA BIOLOGICS INC | $8.81 | $9.02 | -2.36% | 12.77x | 10.50x | 4.08x | 5.23x | 0.53x | $107.90M | 5.19% | $390.33M | 1.65 | $2.10B | 9.49 | ||
| ASND | ASCENDIS PHARMA A | $259.80 | $79.29 | 227.67% | 27.54x | 17.70x | 15.84x | 28.11x | 2.80x | $52.94M | 0.33% | $574.09M | 9.24 | $16.52B | 177.12 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $242.18 | $48.19 | 402.52% | 515.28x | 9.36x | 3.38x | 3.35x | 1.74x | $1.30B | 8.66% | $4.53B | 73.22 | $18.75B | 27.78 | ||
| TGTX | TG THERAPEUTICS INC | $54.93 | $20.43 | 168.86% | 17.06x | 39.52x | 11.33x | 14.42x | 4.77x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.72B | 58.11 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.53 | $35.12 | -4.52% | 13.25x | 9.18x | 2.16x | 2.13x | 0.50x | $341.79M | 17.63% | $910.35M | 15.75 | $1.51B | 6.37 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $296.45 | $92.54 | 220.36% | 37.53x | 32.66x | 21.47x | 5.96x | 1.89x | $122.22M | 2.07% | $997.32M | 50.16 | $6.28B | 27.83 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.57 | $8.80 | -82.17% | 5.81x | -5.31x | 1.47x | 1.72x | 0.07x | $7.24M | 8.03% | $52.93M | 0.92 | $37.25M | 2.40 | ||
| TECH | BIO-TECHNE CORP | $71.77 | $16.42 | 337.00% | 101.08x | 34.40x | 9.27x | 5.39x | 1.85x | $269.60M | 2.40% | $2.09B | 13.34 | $11.32B | 44.21 | ||
| UTHR | UNITED THERAPEUTICS CORP | $529.05 | $237.06 | 123.17% | 18.07x | 19.05x | 7.26x | 3.81x | 2.03x | $1.02B | 4.42% | $5.90B | 135.66 | $21.18B | 12.36 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.40 | $2.41 | 40.99% | 14.17x | 14.37x | 2.08x | 3.29x | 0.96x | $4.11M | 1.50% | $82.33M | 1.03 | $206.82M | 9.74 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $486.03 | $164.66 | 195.18% | 28.57x | 24.86x | 10.11x | 6.37x | 2.09x | $3.71B | 3.00% | $19.36B | 76.20 | $119.85B | 22.22 | ||
| EXEL | EXELIXIS INC | $55.68 | $30.49 | 82.64% | 17.85x | 17.11x | 6.05x | 7.23x | 1.28x | $917.69M | 6.38% | $1.94B | 7.49 | $13.94B | 13.20 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $678.94 | $427.33 | 58.88% | 15.95x | 14.42x | 4.73x | 2.27x | 1.08x | $4.11B | 5.82% | $31.42B | 302.15 | $70.92B | 12.35 | ||
| INCY | INCYTE CORP | $116.65 | $63.66 | 83.25% | 16.00x | 14.74x | 4.34x | 4.14x | 1.48x | $1.45B | 6.24% | $5.62B | 28.21 | $19.88B | 10.62 | ||
| VCYT | VERACYTE INC | $59.22 | $7.47 | 693.13% | 53.35x | 53.40x | 8.69x | 3.51x | 11.27x | $155.34M | 3.30% | $1.34B | 16.90 | $4.50B | 39.11 | ||
| MDXG | MIMEDX GROUP INC | $4.43 | $1.22 | 264.21% | 21.10x | -52.61x | 1.69x | 2.72x | 11.11x | $69.36M | 10.54% | $242.94M | 1.64 | $517.65M | 9.50 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.23 | $3.19 | 440.37% | 28.72x | 4.70x | 0.83x | 1.21x | 63.98x | $109.24M | 6.04% | $1.51B | 14.34 | $2.39B | 28.90 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.